Yukihide Watanabe
Tsukuba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Role of PCSK9 in breast cancer: a systematic review of its mechanistic pathways and clinical relevance.
Journal: Frontiers in pharmacology
Published: April 07, 2026
Tumor-expressed GPNMB orchestrates Siglec-9+ TAM polarization and EMT to promote metastasis in triple-negative breast cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 02, 2025
TMEPAI Confers Paclitaxel Resistance in Triple-Negative Breast Cancer Cells by Promoting AKT Phosphorylation and Its Downstream Cascade.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: June 25, 2025
Survivin knockout attenuates the progressiveness of BT549 triple negative-breast cancer cells: an in vitro study highlighting stemness and cellular stress response mechanisms.
Journal: Molecular biology reports
Published: March 25, 2025
Dual sgRNA-directed knockout survivin gene expression using CRISPR/Cas9 technology for editing survivin gene in triple-negative breast cancer.
Journal: Narra J
Published: July 15, 2024
THG-1/TSC22D4 Promotes IL-1 Signaling through Stabilization of TRAF6 in Squamous Cell Carcinoma.
Journal: Molecular cancer research : MCR
Published: February 08, 2024
The liver kinase B1 supports mammary epithelial morphogenesis by inhibiting critical factors that mediate epithelial-mesenchymal transition.
Journal: Journal of cellular physiology
Published: April 01, 2022
PMEPA1/TMEPAI Is a Unique Tumorigenic Activator of AKT Promoting Proteasomal Degradation of PHLPP1 in Triple-Negative Breast Cancer Cells.
Journal: Cancers
Published: August 18, 2021
TGF-β-Induced TMEPAI Promotes Epithelial-Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration.
Journal: Breast cancer (Dove Medical Press)
Published: June 19, 2021
PMEPA1/TMEPAI isoforms function via its PY and Smad-interaction motifs for tumorigenic activities of breast cancer cells.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: October 26, 2019
TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel.
Journal: Journal of experimental pharmacology
Published: October 18, 2019
Last Updated: 09/26/2026